Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease.

MLA

Dinoto, Alessandro, et al. “Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease.” Frontiers in Neurology, vol. 13, Mar. 2022, pp. 1–13. EBSCOhost, https://doi.org/10.3389/fneur.2022.866824.

APA

Dinoto, A., Sechi, E., Flanagan, E. P., Ferrari, S., Solla, P., Mariotto, S., & Chen, J. J. (2022). Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease. Frontiers in Neurology, 13, 1–13. https://doi.org/10.3389/fneur.2022.866824

Chicago

Dinoto, Alessandro, Elia Sechi, Eoin P. Flanagan, Sergio Ferrari, Paolo Solla, Sara Mariotto, and John J. Chen. 2022. “Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease.” Frontiers in Neurology 13 (March): 1–13. doi:10.3389/fneur.2022.866824.